GLP1-SEMA

Semaglutide is a modified GLP-1 analogue studied as an agonist of the GLP-1 receptor. Laboratory work commonly examines receptor binding, cyclic-AMP signaling, receptor trafficking, and peptide stability. For laboratory research and analytical use only. Not intended for human or veterinary use, diagnosis, treatment, prevention, mitigation, or cure of any disease. No therapeutic or performance claims are made. Researchers are responsible for appropriate handling, institutional review, and compliance with all applicable laws and regulations.